| Product Name | NebuSelect™ Recombinant Human PLA2G7, His-tag |
|---|---|
| Catalog Number | NBL-242192 |
| Alias/Synonyms | PLA2G7; LDL-PLA2; PAFAD; PAFAH |
| Appearance | see COA |
| Molecule Weight | Phe22-Asn441 |
| CAS | N/A |
| Solubility | Water Soluble |
| Storage | Short term 4℃; Long term -20℃. |
| Shelf Life | 2 years |
| Additional info 1 | Q13093 |
| Additional info 2 |
| Catalog Numbe | Size | Price | Inventory Level | |
| NBL-242192-100ug | 100ug | Inquire | Inquire | |
| NBL-242192-1mg | 1mg | Inquire | Inquire | |
| NBL-242192-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Human PLA2G7, His-tag
Catalog#:
NBL-242192
Description:
NebuSelect™ Recombinant Human PLA2G7, His-tag(Cat#NBL-242192) is expressed in HEK293 with His tag at the C-Terminus.It contains Phe22-Asn441.
Species:
Human
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 48.9 kDa. Due to glycosylation, the protein migrates to 49-60 kDa based on Bis-Tris PAGE result.
Target Name:
PLA2G7; LDL-PLA2; PAFAD; PAFAH
Target Information:
Endogenous PLA2G7 transcription levels were found to be significantly lower in vascular related cell lines than in the other cell lines. Luciferase reporter gene assays indicated that gene activity was significantly enhanced by PLA2G7 promoter fragment. LA2G7 transcription was found to be up-regulated with the treatment of DAC. The 17-β-estradiol was found to down-regulate PLA2G7 transcription in all the cell lines.
Amino Acid Sequence:
Phe22-Asn441
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.